Coronavirus Update: A Key Vaccine Partnership, Promising Treatments, And A Rocky First Quarter
Executive Summary
A new COVID-19 vaccine dream team, updated trial results on remdesivir, and a rough first quarter for big pharma stocks. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, these three topics are among a selection of brief insights we’re bringing you on biopharma commercial activities.
You may also be interested in...
Multiple Coronavirus Vaccines Is Policy Aim, But Will Complicate Supply Chain
At Senate hearing, FDA and NIH officials say government and vaccine developers are outlining production needs with ability to shift manufacturing from their candidates to others to ensure production of the most promising products. FDA Commissioner Hahn says as an essential worker he would break quarantine if needed at a critical White House or other meeting.
WHO Launches Global Push For Tools To Tackle COVID-19
A global collaboration initiative launched by the World Health Organization is intended to foster the development of COVID-19 vaccines, medicines and diagnostics and to make sure they reach all those who need them.
WHO Launches Global Push For Tools To Tackle COVID-19
A global collaboration initiative launched by the World Health Organization is intended to foster the development of COVID-19 diagnostics, vaccines and medicines and to make sure they reach all those who need them.